Showing results (2111-2120 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|December 12, 2003
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humansAndrea Leonardi, Mark B Abelson
Clinical Therapeutics|December 12, 2003
Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparinDaniel D Gretler
Clinical Therapeutics|December 12, 2003
Tolerability and effects on quality of life of twice-daily extended-release carbamazepine in adults with seizure disorders: an open-label, 12- to 36-month continuation studyR Edward Hogan, William R Garnett, Vijay M Thadani, et al.
Clinical Therapeutics|December 12, 2003
Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the NetherlandsJasper M Bos, Hans Rümke, R Welte, et al.
Clinical Therapeutics|September 1, 1992
Issues in drug-related performance impairmentT Roth, T A Roehrs, H Moskowitz
Clinical Therapeutics|September 1, 1992
Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin VR G Deeter, D L Kalman, M P Rogan, et al.
Clinical Therapeutics|November 8, 2003
Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitorLilyAnn Jeu, Judy W M Cheng
Clinical Therapeutics|November 8, 2003
Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United StatesChristopher E Bell, Marc F Botteman, Xin Gao, et al.
Clinical Therapeutics|December 25, 2003
(Unlearned) lessons from John Graunt and Kenneth Rothman: a "CLASSic" exampleFelix M Arellano, Jordi Castellsague,
Clinical Therapeutics|December 25, 2003
Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort studyRajesh Balkrishnan, Rukmini Rajagopalan, Fabian T Camacho, et al.
Pageof 680